News

Jan 02
Press release on the reopening of trading in ASIT Biotech

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT Biotech, ISIN BE0974289218, on Euronext Brussels will re-open on 15/09/2021 at 09:00 CET. Source: FSMA

Jan 02
VCs don't understand that Cardano has a community: Charles Hoskinson

Hoskinson also highlighted the need to change Silicon Valley’s “bizarre mantra of move fast and break things” in crypto, which caused losses of $10.5 billion in the decentralized finance (DeFi) space in 2021. 17902 Total views 63 Total shares In a recent YouTube video, Charles Hoskinson highlighted the rapid growth of the Cardano (ADA) ecosystem […]

Jan 02
DAOs are the foundation of Web3, the creator economy and the future of work

Decentralized autonomous organizations (DAOs) started out as a simple concept envisioned as organizations, created by an idea and fueled by developers, that automate business functions and processes by leveraging smart contracts and all the fundamental tenets of blockchain. The core idea was to flatten the complex business process that various organizations are mired in and […]

Jan 02
The year for Bitcoin — A 2021 roundup of the flagship crypto

While 2021 did provide some sort of respite for investors operating across the global crypto landscape, it was still largely been driven by fears that first reared their ugly heads back in 2020. From rising inflation rates to another wave of coronavirus-related outbreaks, the ground beneath everyone’s feet continued to move even without them knowing.  […]

Jan 02
Biogen shares slump after Samsung Biologics denial of buyout report

Steven Goldstein is based in London and responsible for MarketWatch’s coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch’s economic, political and regulatory coverage. Follow Steve on Twitter: @MKTWgoldstein. Source: Marketwatch

Jan 01
J&J's COVID-19 vaccine booster was 85% effective against hospitalization, in South Africa study

Johnson & Johnson JNJ, -0.72% said Thursday that a South African Phase 3 study showed that its a booster shot of its COVID-19 vaccine was 85% effective in preventing COVID-19-related hospitalization. The drug maker said the study, conducted by the South African Medical Research Council, was conducted from mid-November to mid-December, which is after omicron […]